首页 | 本学科首页   官方微博 | 高级检索  
     

MicroRNA-101真核表达载体的构建及其在人胎盘绒毛癌中的表达
引用本文:李敏,刘志学,刘特,程蔚蔚,高泳涛,王慧. MicroRNA-101真核表达载体的构建及其在人胎盘绒毛癌中的表达[J]. 中国临床医学, 2010, 17(5): 627-630
作者姓名:李敏  刘志学  刘特  程蔚蔚  高泳涛  王慧
作者单位:1. 上海市嘉定区中医医院,上海,201800
2. 同济大学生命科学与技术学院,上海,200092
3. 上海交通大学医学院附属国际和平妇幼保健院,上海,200030
基金项目:上海市科委基础研究重点项目,上海市卫生局青年课题基金,上海市科委自然科学(医学引导类)基金,上海交通大学"医理(工)交叉"研究基金 
摘    要:目的:研究外源性microRNA-101前体的真核表达载体构建方法和其在人胎盘绒毛癌细胞JAR中的表达,及其对靶基因EZH2的沉默作用。方法:利用化学合成法合成microRNA-101前体分子(pre-microRNA-101)并克隆至真核表达载体pR-NAT-CMV3.2/Neo。通过酶切及测序法验证该阳性重组质粒pRNAT-CMV3.2-mir101的正确性。体外培养人胎盘绒毛癌细胞JAR;利用脂质体转染法将空白质粒及重组子pRNAT-CMV3.2-mir101转染至JAR细胞。应用Northern blotting检测各组细胞之间成熟microRNA-101(mature microRNA-101)的表达情况;应用Western blotting检测各组细胞中JAR的表达情况。结果:质粒酶切及测序结果显示pRNAT-CMV3.2-mir101上的microRNA-101与合成的pre-microRNA-101寡核苷酸序列完全一致,无碱基的突变和缺失。Northern blotting结果显示,pRNAT-CMV3.2-mir101转染组细胞的总RNA中含有mi-croRNA-101阳性条带,说明该细胞中mature microRNA-101呈高水平表达。Western blotting结果表明,pRNAT-CMV3.2-mir101转染组JAR细胞中的EZH2蛋白表达量(52.76±3.12)%低于对照组(81.18±2.96)%,两者具有显著差异(P〈0.05)。结论:通过构建真核细胞表达质粒可以高效表达外源性microRNA分子;microRNA-101可以有效地沉默宿主细胞JAR中靶基因EZH2的表达。

关 键 词:小分子RNA  人胎盘绒毛癌  zeste基因增强子  表观遗传学

The Built Eukaryotic Expression Vector of microRNA-101 and the Expression in the Human Placenta Carcinoma Cells
LI Min,LIU Zhixue,LIU Te,CHENG Weiwei,GAO Yongtao,WANG Hui. The Built Eukaryotic Expression Vector of microRNA-101 and the Expression in the Human Placenta Carcinoma Cells[J]. Chinese Journal Of Clinical Medicine, 2010, 17(5): 627-630
Authors:LI Min  LIU Zhixue  LIU Te  CHENG Weiwei  GAO Yongtao  WANG Hui
Affiliation:LI Min1 LIU Zhixue2 LIU Te3 CHENG Weiwei3 GAO Yongtao3 WANG Hhi3 1.Shanghai Jiading Hospital of TCM,Shanghai 201800,China;2.School of Life Science and Technology,Tongji University,Shanghai 200092,China;3.The International Peace Maternity and Child Health Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Shanghai 200030,China
Abstract:Objective: To study the eukaryotic expression vector of microRNA-101 built,its expression in the human placenta carcinoma cells JAR,and its silent function of target gene EZH2.Methods:The molecular pre-microRNA-101 was synthesized by a chemical method,which was cloned on the eukaryotic expression vector pRNAT-CMV3.2/Neo.Then the restriction endonuclease cleaved and DNA sequenced methods were used to assay the positive clone pRNAT-CMV3.2-mir101 accurately.Human placenta carcinoma cell JAR was cultured in vitro,both blank plasmid and positive clone pRNAT-CMV3.2-mir101 were transfected by lipofectamine 2000 kit.The mature microRNA-101 expression in each groups were tested by Northern Blotting.The total proteins of different groups were extracted and the expression of EZH2 each groups were tested by Western blotting.Results: The results of restriction endonuclease cleaved and DNA sequenced indicated that the DNA sequences of positive recombinant clone were in conformity with the pre-microRNA-101 fragment.The results of Northern blotting indicated there was an obvious hybridization band from the pRNAT-CMV3.2-mir101 transfected group.And the microRNA-101 expressed in JAR cells could decrease the expression of EZH2(52.76±3.12) % compared with the blank plasmid.There were significant difference in two groups(P0.05).Conclusions: The mature microRNA-101 expression vector pRNAT-CMV3.2-mir101 is built succeed.In addition the microRNA-101 could interfere the target gene EZH2 expression in JAR growth in vitro.
Keywords:MicroRNA  Human placenta carcinoma cells  Zeste homolog 2  Epigenetic
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号